Split Protein Synthesis Inhibitor for Spatial and Temporal Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing genetically encoded protein synthesis inhibitors, such as ribosome-inactivating proteins (RIPs), irreversibly inhibit protein synthesis in eukaryotic cells, lacking spatial and temporal control, which hampers their use in molecular-biological, physiological, and pharmaceutical studies.
Innovation Solution
An expression system for a genetically encoded protein synthesis inhibitor is developed, comprising two separate nucleic acid sequences encoding components of a modified RIP, which form a complex with RNA N-glycosidase activity only when expressed together, allowing spatial and temporal control of protein synthesis inhibition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a complete RIP is expressed to achieve strong protein synthesis inhibition, then inhibition efficacy is improved, but spatial and temporal control is lost
Solution Approach 1:
The RIP is divided into two separate components (first component with RNA N-glycosidase domain and second component with lectin domain) that are encoded by separate nucleic acid sequences. Each component alone is inactive, but when both are present they form a functional complex that inhibits protein synthesis. This segmentation enables independent control of each component's expression, providing spatial and temporal regulation while maintaining inhibition efficacy when both are expressed together.
2Adaptability or versatility
If RIP expression is made controllable for spatial and temporal regulation, then adaptability is improved, but inhibition strength is reduced
Solution Approach 1:
By separating the RIP into two components that must both be present for activity, the system achieves controllable inhibition. The first component contains the RNA N-glycosidase domain responsible for catalytic activity, while the second component contains the lectin domain. When both components are expressed together under controllable promoters, they form an active complex that restores full inhibition efficacy while allowing spatial and temporal regulation through independent expression control.
3Ease of repair
If protein synthesis inhibition is made reversible, then cellular recovery is improved, but mechanism complexity increases
Solution Approach 1:
The reversible inhibition mechanism relies on the segmented design where the first component (RNA N-glycosidase domain) and second component (lectin domain) can be independently regulated. When expression of one or both components is stopped, the existing protein complexes gradually degrade and are replaced by new proteins, allowing cellular recovery. The modular nature of the system simplifies the reversal process compared to irreversible RIPs, as simply stopping expression enables recovery without requiring additional degradation mechanisms.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides reversible and cell-type-specific inhibition of protein synthesis, enabling targeted insights into cellular functions and therapeutic applications in conditions like cancer and neurological disorders.
Implementation Method 1
RIPs display rRNA N-glycosidase activity (EC 3.2.2.22) and depurinate 28S rRNA by cleaving the bond between adenine and ribose in the sarcin-ricin loop of the molecule, thus preventing regroupment of translation elongation factors in subsequent protein synthesis.
Data Source
AI summary
The present invention relates to an expression system for a genetically encoded protein synthesis inhibitor containing RNA N-glycosidase activity split into two components. The expression system can be combined with genetic targeting systems to achieve cell- and/or tissue-type-specific and/or temporally-specific control of protein synthesis in a host, particularly in a mammalian host.